Equity Analysis

Quarterly Results

    Zim Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    541400
    INE518E01015
    48.1042377
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ZIMLAB
    34.49
    507.48
    EPS(TTM)
    Face Value()
    Div & Yield %:
    3.02
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales89.7282.00117.39
Other Operating Income0.000.000.00
Other Income 1.320.981.53
Total Income91.0482.98118.92
Total Expenditure 81.3374.13101.96
PBIDT9.718.8616.96
Interest 2.892.862.28
PBDT6.836.0014.68
Depreciation4.974.923.87
Tax0.240.21-1.29
Fringe Benefit Tax0.000.000.00
Deferred Tax0.400.124.20
Reported Profit After Tax1.220.767.89
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item1.220.767.89
EPS (Unit Curr.)0.250.161.62
EPS (Adj) (Unit Curr.)0.250.161.62
Calculated EPS (Unit Curr.)0.250.161.62
Calculated EPS (Adj) (Unit Curr.)0.250.161.62
Calculated EPS (Ann.) (Unit Curr.)1.000.626.48
Calculated EPS (Adj) (Ann.) (Unit Curr.)1.000.626.48
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity48.7348.7348.73
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)10.8210.8014.45
PBDTM(%)7.617.3212.51
PATM(%)1.360.936.72
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.250.161.62